Sejong Medical Co., Ltd.

Equities

A258830

KR7258830009

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. Other stock markets 23:00:00 28/03/2024 GMT			5-day change	1st Jan Change
412 ^KRW	+26.77%		-.--%	-64.17%

05-14	Sejong Medical Co., Ltd. cancelled the transaction announced on November 7, 2022	CI
2023	Sejong Medical Co., Ltd.(KOSDAQ:A258830) dropped from S&P Global BMI Index	CI

Tranche Update on Sejong Medical Co., Ltd.'s Equity Buyback Plan announced on December 4, 2018.

January 09, 2019

From December 4, 2018 to January 8, 2019, the company has repurchased 80,000 shares, representing 1.46% for KRW 931.99 million. With this, the company has completed the repurchase of 80,000 shares, representing 1.46% for KRW 931.99 million under the buyback announced on December 4, 2018.

Latest news about Sejong Medical Co., Ltd.

Sejong Medical Co., Ltd. cancelled the transaction announced on November 7, 2022	05-13	CI
Sejong Medical Co., Ltd.(KOSDAQ:A258830) dropped from S&P Global BMI Index	18/09/23	CI
Sejong Medical Co., Ltd. announced that it has received KRW 3.5 billion in funding	30/07/23	CI
Sejong Medical Co., Ltd. announced that it has received KRW 30 billion in funding from Helixmith Co., Ltd	28/12/22	CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 3 billion in funding	25/12/22	CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 30 billion in funding from Helixmith Co., Ltd	20/12/22	CI
Doowon Science Pharmaceutical Co., Ltd. announced that it expects to receive KRW 1.16 billion in funding from Sejong Medical Co., Ltd.	11/12/22	CI
Sejong Medical Co., Ltd. agreed to acquire unknown minority stake in Doowon Science Pharmaceutical Co., Ltd. for KRW 3.5 billion.	11/12/22	CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 3.5 billion in funding	11/12/22	CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 19.99999948 billion in funding from CANARIABIO M Inc.	06/11/22	CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 19.99999948 billion in funding from CANARIABIO M Inc.	06/11/22	CI
An unknown buyer agreed to acquire 2.5679% stake in Sejong Medical Co., Ltd. from CANARIABIO M Inc. for KRW 6.3 billion.	03/11/22	CI
Sejong Medical Co., Ltd. announced that it has received KRW 80 billion in funding from CANARIABIO M Inc.	12/10/22	CI
CANARIABIO Inc. announced that it has received KRW 29.999997555 billion in funding from Sejong Medical Co., Ltd.	11/10/22	CI
CANARIABIO Inc. announced that it expects to receive KRW 19.99999837 billion in funding from Sejong Medical Co., Ltd.	03/10/22	CI
CANARIABIO M Inc. completed the acquisition of Sejong Medical Co., Ltd. (KOSDAQ : A258830) from Lee, Jae Chul & others.	29/09/22	CI
Sejong Medical Co., Ltd.(KOSDAQ:A258830) added to S&P Global BMI Index	19/09/22	CI
CANARIABIO M Inc. agreed to acquire a 40% stake in Sejong Medical Co., Ltd. (KOSDAQ : A258830) from Lee, Jae Chul for KRW 45 billion.	17/07/22	CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 50 billion in funding from CANARIABIO M Inc.	14/07/22	CI
Sejong Medical Co., Ltd. announced that it has received KRW 20 billion in funding from Meritz Securities Co., Ltd., Investment Arm	11/01/22	CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 20 billion in funding from Meritz Securities Co., Ltd., Investment Arm	28/11/21	CI
Sejong Medical Co., Ltd. acquired 14.01% stake in Genencell Co., Ltd from Se-chan Kang for KRW 6.3 billion.	19/10/21	CI
Sejong Medical Co., Ltd. announced that it has received KRW 32.49815256 billion in funding from Time Investment Co., Ltd, and other investors	16/09/21	CI
Sejong Medical Co., Ltd. announced that it expects to receive KRW 32.49815256 billion in funding from Time Investment Co., Ltd, and other investors	22/07/21	CI
Sejong Medical Co., Ltd. agreed to acquire 29.4% stake in Yozma BMTECH CO,LTD. for KRW 3.7 billion .	12/07/20	CI

Chart Sejong Medical Co., Ltd.

Duration

Period

More charts

Company Profile

SEJONG MEDICAL Co.Ltd., is a Korea-based company principally engaged in the manufacturing and sale of laparoscopic surgery equipments. The Company manufactures and sells laparoscopic surgery trocar, laparoscopic bags, and laparoscopic loop. The Company distributes its products within the domestic market and to overseas markets, including Europe, Asia and North America.

Sector

Medical Equipment, Supplies & Distribution

Calendar

08/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Supplies

	1st Jan change	Capi.
SEJONG MEDICAL CO., LTD.	-64.17%	16.6M
COLOPLAST A/S	+6.84%	27.04B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-40.08%	2.82B
WINNER MEDICAL CO., LTD.	-19.95%	2.42B
HARTALEGA HOLDINGS	+16.30%	2.32B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+7.28%	2.22B
TOP GLOVE CORPORATION BHD.	+16.67%	1.8B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-13.56%	1.8B
GVS S.P.A.	+18.92%	1.25B
KOSSAN RUBBER INDUSTRIES	+20.00%	1.21B

Medical Supplies